TrialInternational journal of gynecological cancer : official journal of the International Gynecological Cancer Society2021

Rucaparib maintenance treatment for recurrent ovarian carcinoma: the effects of progression-free interval and prior therapies on efficacy and safety in the randomized phase III trial ARIEL3.

Andrew R Clamp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.